Industry News
CIRS is delighted to announce that we will be exhibiting at the PCHi in Hangzhou, China between 18-20 March, 2026.
On January 29, 2026, the European Commission published Directive (EU) 2026/192, amending the Toy Safety Directive 2009/48/EC to permit the use of cobalt in three specific applications within toys.
On February 4, 2026, ECHA announced the official inclusion of n-Hexane and 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (BPAF) and its salts into the SVHC candidate list.
On February 2, 2026, the Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare, announced a revision to the annex of the Documentation Required for Case-by-Case Review of Applications for the Use of Human Cell-Derived Exosomes in Cosmetics. The revised annex takes effect immediately upon the date of announcement.
The Labeling of Hazardous Art Materials Act (LHAMA) requires all art materials to be evaluated for chronic health hazards. Materials posing such risks must have appropriate warning labels. This law applies to all art materials, not just those for children. Under U.S. Consumer Product Safety Commission (CPSC) regulations (16 CFR §1500.14(b)(8)), art materials must undergo LHAMA assessment and labeling in accordance with ASTM D4236.
On January 15, 2025, China’s National Institutes for Food and Drug Control (NIFDC) issued a notice announcing the release of three draft cosmetic standards aimed at further enhancing the country’s technical framework for cosmetics. The drafts are now open for public consultation, with the deadline for submitting comments set for February 24, 2026.
On January 12, 2026, the New Jersey State Senate passed Bill S1221, officially titled the Protecting Against Forever Chemicals Act.
Recently, the Connecticut Department of Energy and Environmental Protection (DEEP) has approved “Words or Symbols” informing the purchaser of PFAS in a product.
